Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG).

Source:http://linkedlifedata.com/resource/pubmed/id/21270624

Download in:

View as

General Info

PMID
21270624